Clin2
NCT06188923Possibly a fitRecruiting

Pregnenolone for anxiety and depression in veterans

Anxiety and Depression

Treatments studied

Part of Mental health, Pain clinical trials.

This trial tests whether a dietary supplement called pregnenolone can help veterans with anxiety and depression feel better and function better. It's a new approach that may be added to your current treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
84 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a veteran getting care at the Durham VA.
  • You have at least moderate symptoms of anxiety and depression (score of 20 or higher on a combined questionnaire).
  • If you are a woman of childbearing age, you must use a non-hormonal birth control method (like a copper IUD or condoms).
  • You cannot have a current PTSD diagnosis or have high PTSD symptoms.
  • You cannot be taking benzodiazepines (like Xanax) or opioid painkillers.
  • You cannot be pregnant or breastfeeding.
  • Your psychiatric medications must be stable (no changes planned) for the study duration, and no changes in the 4 weeks before starting.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05935761Not yet recruiting· Phase 2
Trial testing new treatments for long-term back pain

This Phase 2 trial studies new treatment approaches for chronic low back pain in U.S. military veterans. It aims to see whether the interventions can reduce pain over about 6 weeks without requiring major medication changes.

Durham, North Carolina
NCT07734701Not yet recruiting· Phase 2
Pregnenolone for alcohol use and depression

This trial tests if a natural steroid called pregnenolone can help people who have both alcohol use disorder and major depression. You would take the study medication for several weeks and have brain scans and mood assessments to see if it reduces drinking and improves mood.

Dallas, Texas
NCT05570812Recruiting· Phase 2
Pregnenolone to improve depressed mood in people with HIV

This Phase 2 trial tests a brain-acting steroid called pregnenolone to help reduce depressed mood. It studies whether it can improve mood in adults with HIV who are already on HIV treatment and still have depression symptoms.

Boston, Massachusetts
NCT06238700Recruiting
Studying allopregnanolone for depression in midlife women

This trial tests whether allopregnanolone, a natural brain chemical, can help depression in women going through menopause. It compares the effects against a placebo to see if it improves mood symptoms.

Boston, Massachusetts
NCT07685964Not yet recruiting· Phase 1/Phase 2
Pregnenolone for cannabis use and depression

This study tests if a natural hormone called pregnenolone can help people who use cannabis frequently and also have depression. You would take pregnenolone pills and see if your cannabis use and mood improve.

Dallas, Texas
NCT05781009Recruiting· Phase 2
Pregnenolone treatment for alcohol use disorder

This Phase 2 study tests pregnenolone to help reduce or improve alcohol use disorder symptoms. It looks for adults who drink regularly and meet diagnostic criteria for moderate to severe alcohol use disorder, while excluding people with certain other substance use, medicines, or serious mental/medical conditions.

New Haven, Connecticut

Hear when a new Anxiety and Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.